nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP3A4—breast cancer	0.219	1	CbGaD
Ramelteon—CYP1A2—Anastrozole—breast cancer	0.0591	0.114	CbGbCtD
Ramelteon—CYP1A2—Toremifene—breast cancer	0.054	0.104	CbGbCtD
Ramelteon—CYP2C19—Lapatinib—breast cancer	0.0427	0.0823	CbGbCtD
Ramelteon—CYP3A4—Exemestane—breast cancer	0.0408	0.0787	CbGbCtD
Ramelteon—CYP3A4—Letrozole—breast cancer	0.0347	0.0669	CbGbCtD
Ramelteon—CYP3A4—Anastrozole—breast cancer	0.031	0.0596	CbGbCtD
Ramelteon—CYP3A4—Toremifene—breast cancer	0.0283	0.0545	CbGbCtD
Ramelteon—CYP3A4—Fulvestrant—breast cancer	0.0263	0.0507	CbGbCtD
Ramelteon—CYP3A4—Thiotepa—breast cancer	0.0235	0.0452	CbGbCtD
Ramelteon—CYP3A4—Ixabepilone—breast cancer	0.0215	0.0413	CbGbCtD
Ramelteon—CYP2C19—Tamoxifen—breast cancer	0.0214	0.0412	CbGbCtD
Ramelteon—CYP3A4—Lapatinib—breast cancer	0.0207	0.0398	CbGbCtD
Ramelteon—CYP1A2—Tamoxifen—breast cancer	0.0197	0.038	CbGbCtD
Ramelteon—CYP3A4—Raloxifene—breast cancer	0.0157	0.0302	CbGbCtD
Ramelteon—CYP1A2—Fluorouracil—breast cancer	0.0145	0.028	CbGbCtD
Ramelteon—CYP3A4—Vinorelbine—breast cancer	0.0115	0.0221	CbGbCtD
Ramelteon—CYP3A4—Tamoxifen—breast cancer	0.0103	0.0199	CbGbCtD
Ramelteon—CYP3A4—Mitoxantrone—breast cancer	0.0101	0.0194	CbGbCtD
Ramelteon—CYP3A4—Paclitaxel—breast cancer	0.00805	0.0155	CbGbCtD
Ramelteon—CYP3A4—Irinotecan—breast cancer	0.00794	0.0153	CbGbCtD
Ramelteon—CYP3A4—Vinblastine—breast cancer	0.00706	0.0136	CbGbCtD
Ramelteon—CYP3A4—Docetaxel—breast cancer	0.00582	0.0112	CbGbCtD
Ramelteon—CYP3A4—Doxorubicin—breast cancer	0.00434	0.00836	CbGbCtD
Ramelteon—Mental disability—Paclitaxel—breast cancer	0.000598	0.00478	CcSEcCtD
Ramelteon—Anaphylactic shock—Idarubicin—breast cancer	0.000592	0.00474	CcSEcCtD
Ramelteon—Asthenia—Fulvestrant—breast cancer	0.00058	0.00464	CcSEcCtD
Ramelteon—Asthenia—Toremifene—breast cancer	0.000573	0.00458	CcSEcCtD
Ramelteon—Fatigue—Ixabepilone—breast cancer	0.000571	0.00457	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Letrozole—breast cancer	0.000569	0.00455	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Anastrozole—breast cancer	0.000569	0.00455	CcSEcCtD
Ramelteon—Insomnia—Letrozole—breast cancer	0.000565	0.00451	CcSEcCtD
Ramelteon—Insomnia—Anastrozole—breast cancer	0.000565	0.00451	CcSEcCtD
Ramelteon—Somnolence—Letrozole—breast cancer	0.000555	0.00444	CcSEcCtD
Ramelteon—Somnolence—Anastrozole—breast cancer	0.000555	0.00444	CcSEcCtD
Ramelteon—Diarrhoea—Fulvestrant—breast cancer	0.000553	0.00442	CcSEcCtD
Ramelteon—Headache—Lapatinib—breast cancer	0.000551	0.0044	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Raloxifene—breast cancer	0.00054	0.00432	CcSEcCtD
Ramelteon—Fatigue—Letrozole—breast cancer	0.000538	0.0043	CcSEcCtD
Ramelteon—Fatigue—Anastrozole—breast cancer	0.000538	0.0043	CcSEcCtD
Ramelteon—Insomnia—Raloxifene—breast cancer	0.000536	0.00428	CcSEcCtD
Ramelteon—Dizziness—Fulvestrant—breast cancer	0.000535	0.00428	CcSEcCtD
Ramelteon—Dizziness—Toremifene—breast cancer	0.000528	0.00422	CcSEcCtD
Ramelteon—Nausea—Lapatinib—breast cancer	0.000522	0.00418	CcSEcCtD
Ramelteon—Influenza—Gemcitabine—breast cancer	0.000516	0.00413	CcSEcCtD
Ramelteon—Dysgeusia—Tamoxifen—breast cancer	0.000513	0.0041	CcSEcCtD
Ramelteon—Headache—Fulvestrant—breast cancer	0.000507	0.00405	CcSEcCtD
Ramelteon—Asthenia—Exemestane—breast cancer	0.000504	0.00403	CcSEcCtD
Ramelteon—Headache—Toremifene—breast cancer	0.0005	0.004	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Mitoxantrone—breast cancer	0.000493	0.00394	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Irinotecan—breast cancer	0.000493	0.00394	CcSEcCtD
Ramelteon—Mental disability—Capecitabine—breast cancer	0.000491	0.00392	CcSEcCtD
Ramelteon—Diarrhoea—Exemestane—breast cancer	0.000481	0.00384	CcSEcCtD
Ramelteon—Nausea—Fulvestrant—breast cancer	0.00048	0.00384	CcSEcCtD
Ramelteon—Asthenia—Ixabepilone—breast cancer	0.000476	0.0038	CcSEcCtD
Ramelteon—Nausea—Toremifene—breast cancer	0.000474	0.00379	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Fluorouracil—breast cancer	0.000472	0.00377	CcSEcCtD
Ramelteon—Dizziness—Exemestane—breast cancer	0.000465	0.00371	CcSEcCtD
Ramelteon—Diarrhoea—Ixabepilone—breast cancer	0.000454	0.00363	CcSEcCtD
Ramelteon—Asthenia—Letrozole—breast cancer	0.000448	0.00358	CcSEcCtD
Ramelteon—Asthenia—Anastrozole—breast cancer	0.000448	0.00358	CcSEcCtD
Ramelteon—Myalgia—Tamoxifen—breast cancer	0.000446	0.00356	CcSEcCtD
Ramelteon—Arthralgia—Tamoxifen—breast cancer	0.000446	0.00356	CcSEcCtD
Ramelteon—Headache—Exemestane—breast cancer	0.00044	0.00352	CcSEcCtD
Ramelteon—Dizziness—Ixabepilone—breast cancer	0.000438	0.0035	CcSEcCtD
Ramelteon—Myalgia—Melphalan—breast cancer	0.000436	0.00349	CcSEcCtD
Ramelteon—Influenza—Paclitaxel—breast cancer	0.000432	0.00346	CcSEcCtD
Ramelteon—Thinking abnormal—Epirubicin—breast cancer	0.00043	0.00344	CcSEcCtD
Ramelteon—Diarrhoea—Letrozole—breast cancer	0.000427	0.00341	CcSEcCtD
Ramelteon—Diarrhoea—Anastrozole—breast cancer	0.000427	0.00341	CcSEcCtD
Ramelteon—Arthralgia—Goserelin—breast cancer	0.000426	0.0034	CcSEcCtD
Ramelteon—Myalgia—Goserelin—breast cancer	0.000426	0.0034	CcSEcCtD
Ramelteon—Anaphylactic shock—Melphalan—breast cancer	0.000418	0.00334	CcSEcCtD
Ramelteon—Nausea—Exemestane—breast cancer	0.000417	0.00334	CcSEcCtD
Ramelteon—Headache—Ixabepilone—breast cancer	0.000415	0.00332	CcSEcCtD
Ramelteon—Fatigue—Chlorambucil—breast cancer	0.000414	0.00331	CcSEcCtD
Ramelteon—Dizziness—Anastrozole—breast cancer	0.000413	0.0033	CcSEcCtD
Ramelteon—Dizziness—Letrozole—breast cancer	0.000413	0.0033	CcSEcCtD
Ramelteon—Anaphylactic shock—Goserelin—breast cancer	0.000408	0.00326	CcSEcCtD
Ramelteon—Diarrhoea—Raloxifene—breast cancer	0.000405	0.00324	CcSEcCtD
Ramelteon—Diarrhoea—Idarubicin—breast cancer	0.000405	0.00324	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Paclitaxel—breast cancer	0.000402	0.00321	CcSEcCtD
Ramelteon—Thinking abnormal—Doxorubicin—breast cancer	0.000398	0.00318	CcSEcCtD
Ramelteon—Nausea—Ixabepilone—breast cancer	0.000394	0.00315	CcSEcCtD
Ramelteon—Dizziness—Raloxifene—breast cancer	0.000392	0.00313	CcSEcCtD
Ramelteon—Headache—Anastrozole—breast cancer	0.000391	0.00313	CcSEcCtD
Ramelteon—Headache—Letrozole—breast cancer	0.000391	0.00313	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Tamoxifen—breast cancer	0.000389	0.00311	CcSEcCtD
Ramelteon—Insomnia—Tamoxifen—breast cancer	0.000386	0.00309	CcSEcCtD
Ramelteon—Depression—Paclitaxel—breast cancer	0.000384	0.00307	CcSEcCtD
Ramelteon—Myalgia—Vinorelbine—breast cancer	0.000381	0.00305	CcSEcCtD
Ramelteon—Arthralgia—Vinorelbine—breast cancer	0.000381	0.00305	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Melphalan—breast cancer	0.000381	0.00305	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Goserelin—breast cancer	0.000372	0.00297	CcSEcCtD
Ramelteon—Headache—Idarubicin—breast cancer	0.000371	0.00297	CcSEcCtD
Ramelteon—Headache—Raloxifene—breast cancer	0.000371	0.00297	CcSEcCtD
Ramelteon—Nausea—Letrozole—breast cancer	0.000371	0.00296	CcSEcCtD
Ramelteon—Nausea—Anastrozole—breast cancer	0.000371	0.00296	CcSEcCtD
Ramelteon—Insomnia—Goserelin—breast cancer	0.000369	0.00295	CcSEcCtD
Ramelteon—Fatigue—Tamoxifen—breast cancer	0.000368	0.00294	CcSEcCtD
Ramelteon—Anaphylactic shock—Vinorelbine—breast cancer	0.000365	0.00292	CcSEcCtD
Ramelteon—Arthralgia—Thiotepa—breast cancer	0.000364	0.00291	CcSEcCtD
Ramelteon—Myalgia—Thiotepa—breast cancer	0.000364	0.00291	CcSEcCtD
Ramelteon—Somnolence—Goserelin—breast cancer	0.000363	0.0029	CcSEcCtD
Ramelteon—Dysgeusia—Mitoxantrone—breast cancer	0.000362	0.00289	CcSEcCtD
Ramelteon—Fatigue—Melphalan—breast cancer	0.000361	0.00288	CcSEcCtD
Ramelteon—Influenza—Capecitabine—breast cancer	0.000355	0.00284	CcSEcCtD
Ramelteon—Nausea—Raloxifene—breast cancer	0.000352	0.00281	CcSEcCtD
Ramelteon—Nausea—Idarubicin—breast cancer	0.000352	0.00281	CcSEcCtD
Ramelteon—Fatigue—Goserelin—breast cancer	0.000352	0.00281	CcSEcCtD
Ramelteon—Asthenia—Chlorambucil—breast cancer	0.000344	0.00275	CcSEcCtD
Ramelteon—Mental disability—Epirubicin—breast cancer	0.000342	0.00273	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Vinorelbine—breast cancer	0.000333	0.00266	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Capecitabine—breast cancer	0.00033	0.00264	CcSEcCtD
Ramelteon—Diarrhoea—Chlorambucil—breast cancer	0.000328	0.00262	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Thiotepa—breast cancer	0.000318	0.00254	CcSEcCtD
Ramelteon—Mental disability—Doxorubicin—breast cancer	0.000316	0.00253	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Methotrexate—breast cancer	0.000316	0.00252	CcSEcCtD
Ramelteon—Asthenia—Vinblastine—breast cancer	0.000315	0.00252	CcSEcCtD
Ramelteon—Depression—Capecitabine—breast cancer	0.000315	0.00252	CcSEcCtD
Ramelteon—Fatigue—Vinorelbine—breast cancer	0.000315	0.00252	CcSEcCtD
Ramelteon—Myalgia—Mitoxantrone—breast cancer	0.000314	0.00251	CcSEcCtD
Ramelteon—Arthralgia—Mitoxantrone—breast cancer	0.000314	0.00251	CcSEcCtD
Ramelteon—Somnolence—Thiotepa—breast cancer	0.00031	0.00248	CcSEcCtD
Ramelteon—Asthenia—Tamoxifen—breast cancer	0.000306	0.00245	CcSEcCtD
Ramelteon—Myalgia—Gemcitabine—breast cancer	0.000306	0.00245	CcSEcCtD
Ramelteon—Arthralgia—Gemcitabine—breast cancer	0.000306	0.00245	CcSEcCtD
Ramelteon—Anaphylactic shock—Mitoxantrone—breast cancer	0.000301	0.00241	CcSEcCtD
Ramelteon—Anaphylactic shock—Irinotecan—breast cancer	0.000301	0.00241	CcSEcCtD
Ramelteon—Myalgia—Fluorouracil—breast cancer	0.000301	0.00241	CcSEcCtD
Ramelteon—Fatigue—Thiotepa—breast cancer	0.000301	0.00241	CcSEcCtD
Ramelteon—Diarrhoea—Vinblastine—breast cancer	0.000301	0.00241	CcSEcCtD
Ramelteon—Asthenia—Melphalan—breast cancer	0.0003	0.0024	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Epirubicin—breast cancer	0.000295	0.00236	CcSEcCtD
Ramelteon—Dysgeusia—Paclitaxel—breast cancer	0.000295	0.00236	CcSEcCtD
Ramelteon—Anaphylactic shock—Gemcitabine—breast cancer	0.000294	0.00235	CcSEcCtD
Ramelteon—Asthenia—Goserelin—breast cancer	0.000293	0.00234	CcSEcCtD
Ramelteon—Diarrhoea—Tamoxifen—breast cancer	0.000292	0.00234	CcSEcCtD
Ramelteon—Dizziness—Vinblastine—breast cancer	0.000291	0.00232	CcSEcCtD
Ramelteon—Anaphylactic shock—Fluorouracil—breast cancer	0.000289	0.00231	CcSEcCtD
Ramelteon—Diarrhoea—Melphalan—breast cancer	0.000286	0.00229	CcSEcCtD
Ramelteon—Nausea—Chlorambucil—breast cancer	0.000285	0.00228	CcSEcCtD
Ramelteon—Dizziness—Tamoxifen—breast cancer	0.000282	0.00226	CcSEcCtD
Ramelteon—Diarrhoea—Goserelin—breast cancer	0.000279	0.00223	CcSEcCtD
Ramelteon—Headache—Vinblastine—breast cancer	0.000275	0.0022	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Mitoxantrone—breast cancer	0.000275	0.0022	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Doxorubicin—breast cancer	0.000273	0.00219	CcSEcCtD
Ramelteon—Insomnia—Irinotecan—breast cancer	0.000273	0.00218	CcSEcCtD
Ramelteon—Dizziness—Goserelin—breast cancer	0.00027	0.00216	CcSEcCtD
Ramelteon—Somnolence—Mitoxantrone—breast cancer	0.000268	0.00214	CcSEcCtD
Ramelteon—Somnolence—Irinotecan—breast cancer	0.000268	0.00214	CcSEcCtD
Ramelteon—Headache—Tamoxifen—breast cancer	0.000268	0.00214	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Gemcitabine—breast cancer	0.000267	0.00214	CcSEcCtD
Ramelteon—Insomnia—Gemcitabine—breast cancer	0.000266	0.00212	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Fluorouracil—breast cancer	0.000263	0.0021	CcSEcCtD
Ramelteon—Asthenia—Vinorelbine—breast cancer	0.000262	0.0021	CcSEcCtD
Ramelteon—Nausea—Vinblastine—breast cancer	0.000261	0.00209	CcSEcCtD
Ramelteon—Insomnia—Fluorouracil—breast cancer	0.000261	0.00209	CcSEcCtD
Ramelteon—Somnolence—Gemcitabine—breast cancer	0.000261	0.00209	CcSEcCtD
Ramelteon—Fatigue—Irinotecan—breast cancer	0.00026	0.00208	CcSEcCtD
Ramelteon—Fatigue—Mitoxantrone—breast cancer	0.00026	0.00208	CcSEcCtD
Ramelteon—Somnolence—Fluorouracil—breast cancer	0.000257	0.00205	CcSEcCtD
Ramelteon—Myalgia—Paclitaxel—breast cancer	0.000256	0.00205	CcSEcCtD
Ramelteon—Arthralgia—Paclitaxel—breast cancer	0.000256	0.00205	CcSEcCtD
Ramelteon—Headache—Goserelin—breast cancer	0.000256	0.00204	CcSEcCtD
Ramelteon—Nausea—Tamoxifen—breast cancer	0.000254	0.00203	CcSEcCtD
Ramelteon—Fatigue—Gemcitabine—breast cancer	0.000253	0.00202	CcSEcCtD
Ramelteon—Asthenia—Thiotepa—breast cancer	0.00025	0.002	CcSEcCtD
Ramelteon—Diarrhoea—Vinorelbine—breast cancer	0.00025	0.002	CcSEcCtD
Ramelteon—Dysgeusia—Docetaxel—breast cancer	0.00025	0.002	CcSEcCtD
Ramelteon—Nausea—Melphalan—breast cancer	0.000248	0.00199	CcSEcCtD
Ramelteon—Influenza—Epirubicin—breast cancer	0.000247	0.00198	CcSEcCtD
Ramelteon—Anaphylactic shock—Paclitaxel—breast cancer	0.000246	0.00197	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Methotrexate—breast cancer	0.000245	0.00196	CcSEcCtD
Ramelteon—Nausea—Goserelin—breast cancer	0.000242	0.00194	CcSEcCtD
Ramelteon—Dysgeusia—Capecitabine—breast cancer	0.000242	0.00193	CcSEcCtD
Ramelteon—Dizziness—Vinorelbine—breast cancer	0.000242	0.00193	CcSEcCtD
Ramelteon—Diarrhoea—Thiotepa—breast cancer	0.000239	0.00191	CcSEcCtD
Ramelteon—Depression—Methotrexate—breast cancer	0.000235	0.00188	CcSEcCtD
Ramelteon—Dizziness—Thiotepa—breast cancer	0.000231	0.00184	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Epirubicin—breast cancer	0.00023	0.00184	CcSEcCtD
Ramelteon—Headache—Vinorelbine—breast cancer	0.000229	0.00183	CcSEcCtD
Ramelteon—Influenza—Doxorubicin—breast cancer	0.000229	0.00183	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Paclitaxel—breast cancer	0.000224	0.00179	CcSEcCtD
Ramelteon—Insomnia—Paclitaxel—breast cancer	0.000222	0.00178	CcSEcCtD
Ramelteon—Headache—Thiotepa—breast cancer	0.000219	0.00175	CcSEcCtD
Ramelteon—Somnolence—Paclitaxel—breast cancer	0.000218	0.00175	CcSEcCtD
Ramelteon—Myalgia—Docetaxel—breast cancer	0.000217	0.00174	CcSEcCtD
Ramelteon—Arthralgia—Docetaxel—breast cancer	0.000217	0.00174	CcSEcCtD
Ramelteon—Nausea—Vinorelbine—breast cancer	0.000217	0.00174	CcSEcCtD
Ramelteon—Asthenia—Irinotecan—breast cancer	0.000216	0.00173	CcSEcCtD
Ramelteon—Asthenia—Mitoxantrone—breast cancer	0.000216	0.00173	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Doxorubicin—breast cancer	0.000212	0.0017	CcSEcCtD
Ramelteon—Fatigue—Paclitaxel—breast cancer	0.000212	0.00169	CcSEcCtD
Ramelteon—Asthenia—Gemcitabine—breast cancer	0.000211	0.00168	CcSEcCtD
Ramelteon—Arthralgia—Capecitabine—breast cancer	0.00021	0.00168	CcSEcCtD
Ramelteon—Myalgia—Capecitabine—breast cancer	0.00021	0.00168	CcSEcCtD
Ramelteon—Anaphylactic shock—Docetaxel—breast cancer	0.000208	0.00167	CcSEcCtD
Ramelteon—Nausea—Thiotepa—breast cancer	0.000207	0.00166	CcSEcCtD
Ramelteon—Diarrhoea—Irinotecan—breast cancer	0.000206	0.00165	CcSEcCtD
Ramelteon—Diarrhoea—Mitoxantrone—breast cancer	0.000206	0.00165	CcSEcCtD
Ramelteon—Diarrhoea—Gemcitabine—breast cancer	0.000201	0.00161	CcSEcCtD
Ramelteon—Dizziness—Irinotecan—breast cancer	0.000199	0.00159	CcSEcCtD
Ramelteon—Diarrhoea—Fluorouracil—breast cancer	0.000197	0.00158	CcSEcCtD
Ramelteon—Dizziness—Fluorouracil—breast cancer	0.000191	0.00153	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Docetaxel—breast cancer	0.00019	0.00152	CcSEcCtD
Ramelteon—Headache—Irinotecan—breast cancer	0.000189	0.00151	CcSEcCtD
Ramelteon—Headache—Mitoxantrone—breast cancer	0.000189	0.00151	CcSEcCtD
Ramelteon—Insomnia—Docetaxel—breast cancer	0.000188	0.00151	CcSEcCtD
Ramelteon—Somnolence—Docetaxel—breast cancer	0.000185	0.00148	CcSEcCtD
Ramelteon—Headache—Gemcitabine—breast cancer	0.000184	0.00147	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000184	0.00147	CcSEcCtD
Ramelteon—Insomnia—Capecitabine—breast cancer	0.000182	0.00146	CcSEcCtD
Ramelteon—Headache—Fluorouracil—breast cancer	0.000181	0.00145	CcSEcCtD
Ramelteon—Dysgeusia—Methotrexate—breast cancer	0.00018	0.00144	CcSEcCtD
Ramelteon—Fatigue—Docetaxel—breast cancer	0.00018	0.00144	CcSEcCtD
Ramelteon—Nausea—Irinotecan—breast cancer	0.000179	0.00143	CcSEcCtD
Ramelteon—Nausea—Mitoxantrone—breast cancer	0.000179	0.00143	CcSEcCtD
Ramelteon—Asthenia—Paclitaxel—breast cancer	0.000176	0.00141	CcSEcCtD
Ramelteon—Nausea—Gemcitabine—breast cancer	0.000174	0.00139	CcSEcCtD
Ramelteon—Fatigue—Capecitabine—breast cancer	0.000174	0.00139	CcSEcCtD
Ramelteon—Nausea—Fluorouracil—breast cancer	0.000171	0.00137	CcSEcCtD
Ramelteon—Dysgeusia—Epirubicin—breast cancer	0.000169	0.00135	CcSEcCtD
Ramelteon—Diarrhoea—Paclitaxel—breast cancer	0.000168	0.00134	CcSEcCtD
Ramelteon—Dizziness—Paclitaxel—breast cancer	0.000163	0.0013	CcSEcCtD
Ramelteon—Myalgia—Methotrexate—breast cancer	0.000157	0.00125	CcSEcCtD
Ramelteon—Arthralgia—Methotrexate—breast cancer	0.000157	0.00125	CcSEcCtD
Ramelteon—Dysgeusia—Doxorubicin—breast cancer	0.000156	0.00125	CcSEcCtD
Ramelteon—Headache—Paclitaxel—breast cancer	0.000154	0.00123	CcSEcCtD
Ramelteon—Anaphylactic shock—Methotrexate—breast cancer	0.00015	0.0012	CcSEcCtD
Ramelteon—Asthenia—Docetaxel—breast cancer	0.000149	0.00119	CcSEcCtD
Ramelteon—Myalgia—Epirubicin—breast cancer	0.000147	0.00117	CcSEcCtD
Ramelteon—Arthralgia—Epirubicin—breast cancer	0.000147	0.00117	CcSEcCtD
Ramelteon—Nausea—Paclitaxel—breast cancer	0.000146	0.00117	CcSEcCtD
Ramelteon—Asthenia—Capecitabine—breast cancer	0.000145	0.00116	CcSEcCtD
Ramelteon—Diarrhoea—Docetaxel—breast cancer	0.000143	0.00114	CcSEcCtD
Ramelteon—Anaphylactic shock—Epirubicin—breast cancer	0.000141	0.00112	CcSEcCtD
Ramelteon—Diarrhoea—Capecitabine—breast cancer	0.000138	0.0011	CcSEcCtD
Ramelteon—Dizziness—Docetaxel—breast cancer	0.000138	0.0011	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Methotrexate—breast cancer	0.000137	0.00109	CcSEcCtD
Ramelteon—Insomnia—Methotrexate—breast cancer	0.000136	0.00109	CcSEcCtD
Ramelteon—Arthralgia—Doxorubicin—breast cancer	0.000136	0.00108	CcSEcCtD
Ramelteon—Myalgia—Doxorubicin—breast cancer	0.000136	0.00108	CcSEcCtD
Ramelteon—Somnolence—Methotrexate—breast cancer	0.000133	0.00107	CcSEcCtD
Ramelteon—Dizziness—Capecitabine—breast cancer	0.000133	0.00107	CcSEcCtD
Ramelteon—Headache—Docetaxel—breast cancer	0.000131	0.00104	CcSEcCtD
Ramelteon—Anaphylactic shock—Doxorubicin—breast cancer	0.00013	0.00104	CcSEcCtD
Ramelteon—Fatigue—Methotrexate—breast cancer	0.000129	0.00103	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Epirubicin—breast cancer	0.000128	0.00102	CcSEcCtD
Ramelteon—Insomnia—Epirubicin—breast cancer	0.000127	0.00102	CcSEcCtD
Ramelteon—Headache—Capecitabine—breast cancer	0.000126	0.00101	CcSEcCtD
Ramelteon—Somnolence—Epirubicin—breast cancer	0.000125	0.000999	CcSEcCtD
Ramelteon—Nausea—Docetaxel—breast cancer	0.000124	0.000989	CcSEcCtD
Ramelteon—Fatigue—Epirubicin—breast cancer	0.000121	0.000969	CcSEcCtD
Ramelteon—Nausea—Capecitabine—breast cancer	0.00012	0.000958	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Doxorubicin—breast cancer	0.000118	0.000947	CcSEcCtD
Ramelteon—Insomnia—Doxorubicin—breast cancer	0.000118	0.00094	CcSEcCtD
Ramelteon—Somnolence—Doxorubicin—breast cancer	0.000116	0.000924	CcSEcCtD
Ramelteon—Fatigue—Doxorubicin—breast cancer	0.000112	0.000896	CcSEcCtD
Ramelteon—Asthenia—Methotrexate—breast cancer	0.000108	0.000861	CcSEcCtD
Ramelteon—Diarrhoea—Methotrexate—breast cancer	0.000103	0.000821	CcSEcCtD
Ramelteon—Asthenia—Epirubicin—breast cancer	0.000101	0.000806	CcSEcCtD
Ramelteon—Dizziness—Methotrexate—breast cancer	9.93e-05	0.000794	CcSEcCtD
Ramelteon—Diarrhoea—Epirubicin—breast cancer	9.61e-05	0.000769	CcSEcCtD
Ramelteon—Headache—Methotrexate—breast cancer	9.41e-05	0.000752	CcSEcCtD
Ramelteon—Asthenia—Doxorubicin—breast cancer	9.33e-05	0.000746	CcSEcCtD
Ramelteon—Dizziness—Epirubicin—breast cancer	9.29e-05	0.000743	CcSEcCtD
Ramelteon—Nausea—Methotrexate—breast cancer	8.92e-05	0.000713	CcSEcCtD
Ramelteon—Diarrhoea—Doxorubicin—breast cancer	8.9e-05	0.000711	CcSEcCtD
Ramelteon—Headache—Epirubicin—breast cancer	8.8e-05	0.000704	CcSEcCtD
Ramelteon—Dizziness—Doxorubicin—breast cancer	8.6e-05	0.000687	CcSEcCtD
Ramelteon—Nausea—Epirubicin—breast cancer	8.35e-05	0.000667	CcSEcCtD
Ramelteon—Headache—Doxorubicin—breast cancer	8.14e-05	0.000651	CcSEcCtD
Ramelteon—Nausea—Doxorubicin—breast cancer	7.72e-05	0.000617	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—KRAS—breast cancer	1.23e-05	8.99e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—KRAS—breast cancer	1.23e-05	8.99e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.22e-05	8.93e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.21e-05	8.84e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA2—breast cancer	1.2e-05	8.81e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX2—breast cancer	1.2e-05	8.81e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX4—breast cancer	1.19e-05	8.71e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SULT1A1—breast cancer	1.19e-05	8.71e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	1.18e-05	8.67e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALDH1A1—breast cancer	1.18e-05	8.65e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALDH7A1—breast cancer	1.18e-05	8.65e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	1.17e-05	8.55e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—IDH1—breast cancer	1.16e-05	8.5e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTA1—breast cancer	1.16e-05	8.5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SHMT1—breast cancer	1.15e-05	8.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CDA—breast cancer	1.15e-05	8.44e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NAT2—breast cancer	1.15e-05	8.41e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PHGDH—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FHL2—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—UMPS—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ADSL—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NME1—breast cancer	1.13e-05	8.29e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PIK3CA—breast cancer	1.13e-05	8.26e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PIK3CA—breast cancer	1.13e-05	8.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—LDHB—breast cancer	1.11e-05	8.13e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HPSE—breast cancer	1.11e-05	8.13e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BRIP1—breast cancer	1.11e-05	8.13e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A5—breast cancer	1.11e-05	8.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLCO1B1—breast cancer	1.11e-05	8.12e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—breast cancer	1.09e-05	7.99e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—breast cancer	1.09e-05	7.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APRT—breast cancer	1.07e-05	7.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMMR—breast cancer	1.05e-05	7.71e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCC1—breast cancer	1.05e-05	7.71e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA3—breast cancer	1.05e-05	7.71e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HRAS—breast cancer	1.04e-05	7.64e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HRAS—breast cancer	1.04e-05	7.64e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.04e-05	7.6e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PPARGC1B—breast cancer	1.02e-05	7.46e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ESRRA—breast cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ANGPTL4—breast cancer	1.01e-05	7.38e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MED12—breast cancer	1.01e-05	7.37e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—DPYD—breast cancer	1.01e-05	7.37e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—IL6—breast cancer	1e-05	7.32e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—IL6—breast cancer	1e-05	7.32e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	9.93e-06	7.27e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	9.93e-06	7.27e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALDOA—breast cancer	9.92e-06	7.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA4—breast cancer	9.63e-06	7.05e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA9—breast cancer	9.63e-06	7.05e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA3—breast cancer	9.63e-06	7.05e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC2A2—breast cancer	9.56e-06	7e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HADHB—breast cancer	9.56e-06	6.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPI—breast cancer	9.56e-06	6.99e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	9.51e-06	6.96e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	9.46e-06	6.92e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	9.41e-06	6.89e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA2—breast cancer	9.38e-06	6.87e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPX2—breast cancer	9.38e-06	6.87e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CPT1A—breast cancer	9.37e-06	6.85e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTR—breast cancer	9.37e-06	6.85e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCG2—breast cancer	9.37e-06	6.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPX4—breast cancer	9.27e-06	6.78e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SULT1A1—breast cancer	9.27e-06	6.78e-05	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—AKT1—breast cancer	9.22e-06	6.75e-05	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—AKT1—breast cancer	9.22e-06	6.75e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HPGDS—breast cancer	9.18e-06	6.72e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HBA1—breast cancer	9.13e-06	6.68e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALDH1A1—breast cancer	9.12e-06	6.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALDH7A1—breast cancer	9.12e-06	6.67e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTA1—breast cancer	9.05e-06	6.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—IDH1—breast cancer	9.05e-06	6.63e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NAT2—breast cancer	8.95e-06	6.55e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ACHE—breast cancer	8.91e-06	6.52e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—breast cancer	8.91e-06	6.52e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—UMPS—breast cancer	8.74e-06	6.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ADSL—breast cancer	8.74e-06	6.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PHGDH—breast cancer	8.74e-06	6.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NME1—breast cancer	8.74e-06	6.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FHL2—breast cancer	8.74e-06	6.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—LDHB—breast cancer	8.57e-06	6.27e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BRIP1—breast cancer	8.57e-06	6.27e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPSE—breast cancer	8.57e-06	6.27e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP17A1—breast cancer	8.43e-06	6.17e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS1—breast cancer	8.35e-06	6.11e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ENO1—breast cancer	8.35e-06	6.11e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	8.32e-06	6.09e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	8.21e-06	6.01e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP2D6—breast cancer	8.19e-06	5.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCC1—breast cancer	8.13e-06	5.95e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA3—breast cancer	8.13e-06	5.95e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMMR—breast cancer	8.13e-06	5.95e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	8.09e-06	5.92e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA2—breast cancer	8.04e-06	5.88e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PPARGC1B—breast cancer	7.87e-06	5.76e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MED12—breast cancer	7.85e-06	5.75e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—DPYD—breast cancer	7.85e-06	5.75e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—FASN—breast cancer	7.79e-06	5.7e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—BCHE—breast cancer	7.76e-06	5.68e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALDOA—breast cancer	7.73e-06	5.66e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC5A5—breast cancer	7.67e-06	5.61e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA3—breast cancer	7.5e-06	5.49e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC2A2—breast cancer	7.45e-06	5.45e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA4—breast cancer	7.43e-06	5.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA9—breast cancer	7.43e-06	5.44e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NQO1—breast cancer	7.4e-06	5.42e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—SLC2A1—breast cancer	7.4e-06	5.42e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.37e-06	5.4e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CPT1A—breast cancer	7.3e-06	5.34e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTR—breast cancer	7.3e-06	5.34e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCG2—breast cancer	7.3e-06	5.34e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	7.25e-06	5.31e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA2—breast cancer	7.24e-06	5.3e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX2—breast cancer	7.24e-06	5.3e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP3A4—breast cancer	7.22e-06	5.28e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	7.18e-06	5.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HPGDS—breast cancer	7.16e-06	5.24e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SULT1A1—breast cancer	7.15e-06	5.24e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX4—breast cancer	7.15e-06	5.24e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HBA1—breast cancer	7.11e-06	5.2e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1B1—breast cancer	7.1e-06	5.19e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—IDH1—breast cancer	6.99e-06	5.11e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTA1—breast cancer	6.99e-06	5.11e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HSP90AA1—breast cancer	6.96e-06	5.09e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ACHE—breast cancer	6.94e-06	5.08e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—breast cancer	6.94e-06	5.08e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NAT2—breast cancer	6.91e-06	5.06e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOA1—breast cancer	6.77e-06	4.96e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—STK11—breast cancer	6.67e-06	4.88e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP19A1—breast cancer	6.67e-06	4.88e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP17A1—breast cancer	6.57e-06	4.81e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS1—breast cancer	6.5e-06	4.76e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ENO1—breast cancer	6.5e-06	4.76e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.48e-06	4.74e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.4e-06	4.68e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP2D6—breast cancer	6.38e-06	4.67e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	6.26e-06	4.58e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA2—breast cancer	6.26e-06	4.58e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—COMT—breast cancer	6.2e-06	4.54e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTP1—breast cancer	6.17e-06	4.52e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—HMOX1—breast cancer	6.09e-06	4.46e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ITPR1—breast cancer	6.08e-06	4.45e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—FASN—breast cancer	6.07e-06	4.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MED12—breast cancer	6.06e-06	4.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—DPYD—breast cancer	6.06e-06	4.43e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—BCHE—breast cancer	6.05e-06	4.43e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC5A5—breast cancer	5.97e-06	4.37e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALDOA—breast cancer	5.96e-06	4.36e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCB1—breast cancer	5.85e-06	4.28e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA3—breast cancer	5.79e-06	4.24e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NQO1—breast cancer	5.77e-06	4.22e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—SLC2A1—breast cancer	5.77e-06	4.22e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A2—breast cancer	5.75e-06	4.21e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TYMS—breast cancer	5.74e-06	4.2e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.67e-06	4.15e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—breast cancer	5.67e-06	4.15e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NCOR1—breast cancer	5.67e-06	4.15e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.65e-06	4.13e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCG2—breast cancer	5.63e-06	4.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CPT1A—breast cancer	5.63e-06	4.12e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTR—breast cancer	5.63e-06	4.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP3A4—breast cancer	5.63e-06	4.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.6e-06	4.1e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1B1—breast cancer	5.53e-06	4.05e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HPGDS—breast cancer	5.52e-06	4.04e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HBA1—breast cancer	5.49e-06	4.02e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GPX1—breast cancer	5.43e-06	3.98e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HSP90AA1—breast cancer	5.42e-06	3.97e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1A1—breast cancer	5.38e-06	3.94e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ACHE—breast cancer	5.36e-06	3.92e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—breast cancer	5.36e-06	3.92e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ERCC2—breast cancer	5.34e-06	3.9e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOA1—breast cancer	5.28e-06	3.86e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—STK11—breast cancer	5.2e-06	3.81e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP19A1—breast cancer	5.2e-06	3.81e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP17A1—breast cancer	5.07e-06	3.71e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ENO1—breast cancer	5.02e-06	3.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS1—breast cancer	5.02e-06	3.67e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—breast cancer	5.01e-06	3.67e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP2D6—breast cancer	4.92e-06	3.6e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.88e-06	3.57e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—COMT—breast cancer	4.83e-06	3.54e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA2—breast cancer	4.83e-06	3.54e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTP1—breast cancer	4.81e-06	3.52e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—HMOX1—breast cancer	4.75e-06	3.47e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ITPR1—breast cancer	4.73e-06	3.46e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—FASN—breast cancer	4.69e-06	3.43e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—BCHE—breast cancer	4.67e-06	3.42e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CAV1—breast cancer	4.63e-06	3.39e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC5A5—breast cancer	4.61e-06	3.37e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCB1—breast cancer	4.55e-06	3.33e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TYMS—breast cancer	4.47e-06	3.27e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—SLC2A1—breast cancer	4.45e-06	3.26e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NQO1—breast cancer	4.45e-06	3.26e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PLA2G4A—breast cancer	4.42e-06	3.24e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NCOR1—breast cancer	4.42e-06	3.24e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—breast cancer	4.42e-06	3.24e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	4.42e-06	3.23e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1B1—breast cancer	4.27e-06	3.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GPX1—breast cancer	4.23e-06	3.1e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CG—breast cancer	4.21e-06	3.08e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1A1—breast cancer	4.19e-06	3.07e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HSP90AA1—breast cancer	4.19e-06	3.06e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ERCC2—breast cancer	4.16e-06	3.04e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOA1—breast cancer	4.07e-06	2.98e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—STK11—breast cancer	4.01e-06	2.94e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP19A1—breast cancer	4.01e-06	2.94e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—breast cancer	3.91e-06	2.86e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—COMT—breast cancer	3.73e-06	2.73e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTP1—breast cancer	3.71e-06	2.72e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CD—breast cancer	3.7e-06	2.71e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—HMOX1—breast cancer	3.66e-06	2.68e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ALB—breast cancer	3.66e-06	2.68e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ITPR1—breast cancer	3.65e-06	2.67e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CAV1—breast cancer	3.6e-06	2.64e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCB1—breast cancer	3.51e-06	2.57e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NOS3—breast cancer	3.5e-06	2.56e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TYMS—breast cancer	3.45e-06	2.53e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.44e-06	2.52e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NCOR1—breast cancer	3.41e-06	2.5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PLA2G4A—breast cancer	3.41e-06	2.5e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—breast cancer	3.41e-06	2.5e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CG—breast cancer	3.28e-06	2.4e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GPX1—breast cancer	3.27e-06	2.39e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1A1—breast cancer	3.23e-06	2.37e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CB—breast cancer	3.23e-06	2.36e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ERCC2—breast cancer	3.21e-06	2.35e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—breast cancer	3.2e-06	2.34e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—breast cancer	3.02e-06	2.21e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CD—breast cancer	2.89e-06	2.11e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ALB—breast cancer	2.85e-06	2.09e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTEN—breast cancer	2.79e-06	2.04e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CAV1—breast cancer	2.78e-06	2.04e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NOS3—breast cancer	2.73e-06	1.99e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CG—breast cancer	2.53e-06	1.85e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CB—breast cancer	2.52e-06	1.84e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—breast cancer	2.49e-06	1.82e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CD—breast cancer	2.23e-06	1.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ALB—breast cancer	2.2e-06	1.61e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTEN—breast cancer	2.17e-06	1.59e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NOS3—breast cancer	2.1e-06	1.54e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PIK3CA—breast cancer	1.97e-06	1.44e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CB—breast cancer	1.94e-06	1.42e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—breast cancer	1.92e-06	1.41e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTEN—breast cancer	1.68e-06	1.23e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—AKT1—breast cancer	1.61e-06	1.18e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PIK3CA—breast cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—AKT1—breast cancer	1.25e-06	9.17e-06	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PIK3CA—breast cancer	1.18e-06	8.66e-06	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—AKT1—breast cancer	9.67e-07	7.08e-06	CbGpPWpGaD
